FGEN250919C00002500 Option on FibroGen

An 'Out of The Money' option on FibroGen has a strike price that FibroGen Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for FibroGen's 'Out of The Money' options include buying the options if you expect a big move in FibroGen's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

FibroGen's Option Greeks for the contract ending on 2025-09-19 at a strike price of 2.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to FibroGen's option greeks, its implied volatility helps estimate the risk of FibroGen stock implied by the prices of the options on FibroGen's stock.

Put options written on FibroGen grant holders of the option the right to sell a specified amount of FibroGen at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of FibroGen Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on FibroGen is like buying insurance aginst FibroGen's downside shift.

By selling FibroGen's put option, the investors signal their bearish sentiment. A short position in a put option written on FibroGen will generally make money when the underlying price is above the strike price. Therefore FibroGen's put payoff at expiration depends on where the FibroGen Stock price is relative to the put option strike price. The breakeven price of 2.62 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to FibroGen's price. Finally, at the strike price of 2.5, the payoff chart is constant and positive.

FibroGen's option chain is a display of a range of information that helps investors for ways to trade options on FibroGen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for FibroGen. It also shows strike prices and maturity days for a FibroGen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.